Exicure Plans New Clinical Trial for Acute Myeloid Leukemia
Exicure, Inc. (Nasdaq: XCUR) today shared updates on its lead asset, GPC-100 (burixafor), a small molecule CXCR4 inhibitor. Exicure, Inc. (“Exicure”) is planning for a...
Category : Healthcare and Pharmaceutical
ImmunoPrecise AI Platform LENSai™ Aligns with FDA’s New Policy
ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) a leader in AI-driven biotherapeutics, today announced its strong support for the U.S. Food and Drug Administration’s (FDA) recent decision to...
AdvanCell Announces $18M MRFF Funding for Prostate Cancer Therapy
AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced $18M in Australian Federal Government Funding from the Medical Research Future Fund (MRFF) Frontiers...
Savara Announces New Employment Inducement Grant
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to seven new employees. On...
Nuclera Enhances eProtein Discovery for Membrane Protein Production
Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced the addition of a new membrane protein workflow...
Oxford Nanopore Expands Compatible Products Programme
Multiple new partnerships with approved products announced to support broader access to flexible, end-to-end sequencing applications. Oxford Nanopore Technologies today announced the expansion of its...
JAMA Study Confirms Oncotype DX® Test Reliability Across Groups
Comprehensive review confirms that the Oncotype DX Breast Recurrence Score® test accurately predicts breast cancer outcomes and chemotherapy benefit for patients regardless of race or ethnicity...
eXoZymes Launches BioClick with $300K NIH Grant
Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) – a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals –...
Harvard Bioscience Announces CFO Transition
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Jennifer Cote, the Company’s Chief Financial Officer and Treasurer. Ms. Cote’s resignation will...
argenx Gets FDA Nod for VYVGART Self-Injection Prefilled Syringe
argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that...